Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest

Ying Ti Wang, Hsiao Sheng Liu, Chun Li Su

Research output: Contribution to journalArticlepeer-review

19 Citations (Scopus)

Fingerprint Dive into the research topics of 'Curcumin-enhanced chemosensitivity of FDA-approved platinum (II)-based anti-cancer drugs involves downregulation of nuclear endonuclease G and NF-κB as well as induction of apoptosis and G2/M arrest'. Together they form a unique fingerprint.

Medicine & Life Sciences

Agriculture & Biology